- Meeting abstract
- Open Access
Role of a medication in polyurethane foam in the treatment of diabetic foot lesions
© Palumbo et al; licensee BioMed Central Ltd. 2010
- Published: 19 May 2010
- Public Health
- Tissue Sample
- Natural History
- Cardiovascular Event
- Infected Wound
The treatment of diabetic foot lesions need medications capable of managing wound infection and exudates that, variously combined, can influence the natural history of the pathology and therefore limb survival. A particular and economic device, is represented by honeycomb structure polyurethane foam Ligasano ©.
Number of patients
In our experience the device was proved to be economic and manageable, allowing the management of the exudates and avoiding, at the same time, the involvement of the perilesional skin that constitutes itself an innovation on the treatment of diabetic foot lesion.
- Zoellner P, Kapp H, Smola H: A prospective, open-label study to assess the clinical performance of a foam dressing in the management of chronic wounds. Ostomy Wound manage. 2006, 52 (5): 34-6.PubMedGoogle Scholar
- Napoli B, Benigno A, D’Arpa N, Amico M, Conte F: Local treatment of burns with honeycomb expanded polyurethane (Ligasano). Annals of Burns and Fire Disaster. 2008, XXI n.1:Google Scholar
- Zemlin C: Studio sull’impiego di Ligasano come medicazione primaria nelle lesioni del piede di origine diabetica. Ligamed. 2008Google Scholar
This article is published under license to BioMed Central Ltd.